We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.72B
AUM Growth
+$313M
Cap. Flow
+$128M
Cap. Flow %
4.71%
Top 10 Hldgs %
27.21%
Holding
156
New
12
Increased
32
Reduced
20
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 45.7%
2 Technology 19.3%
3 Consumer Discretionary 10.25%
4 Industrials 6.97%
5 Communication Services 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTT
51
DELISTED
GTT Communications, Inc.
GTT
$19.1M 0.7%
441,000
MNTA
52
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$19.1M 0.7%
725,000
+281,000
+63% +$7.6M
SLDB icon
53
Solid Biosciences
SLDB
$836M
$18.9M 0.69%
26,667
STRO icon
54
Sutro Biopharma
STRO
$411M
$18.1M 0.67%
+124,490
New +$18.8M
STML
55
DELISTED
Stemline Therapeutics, Inc.
STML
$18M 0.66%
1,086,400
AY
56
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$17.8M 0.65%
866,000
+2,000
+0.2% +$41K
MTD icon
57
Mettler-Toledo International
MTD
$27.9B
$17.7M 0.65%
29,000
ANET icon
58
Arista Networks
ANET
$215B
$17.5M 0.64%
1,056,000
SNA icon
59
Snap-on
SNA
$21.2B
$16.9M 0.62%
92,000
-2,470
-3% -$431K
PFPT
60
DELISTED
Proofpoint, Inc.
PFPT
$16.8M 0.62%
158,000
HASI icon
61
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$16.1M 0.59%
752,000
+13,000
+2% +$267K
PAYC icon
62
Paycom
PAYC
$7.53B
$14.9M 0.55%
96,000
IMMU
63
DELISTED
Immunomedics Inc
IMMU
$14.6M 0.53%
699,000
CRUS icon
64
Cirrus Logic
CRUS
$6.65B
$14.3M 0.52%
370,000
VKTX icon
65
Viking Therapeutics
VKTX
$3.84B
$13.8M 0.51%
+790,000
New +$9.4M
VYGR icon
66
Voyager Therapeutics
VYGR
$189M
$13.3M 0.49%
703,425
BMRN icon
67
BioMarin Pharmaceuticals
BMRN
$11.7B
$12.8M 0.47%
132,000
+57,000
+76% +$5.69M
VMC icon
68
Vulcan Materials
VMC
$35.2B
$12.2M 0.45%
110,000
SGEN
69
DELISTED
Seagen Inc. Common Stock
SGEN
$11.7M 0.43%
152,000
-405,000
-73% -$29.8M
PTCT icon
70
PTC Therapeutics
PTCT
$6.26B
$11.5M 0.42%
244,000
+175,800
+258% +$7.27M
BHVN
71
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$11M 0.41%
294,000
+40,000
+16% +$1.47M
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11M 0.4%
63,500
DOOR
73
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$10.9M 0.4%
170,000
BOLD
74
DELISTED
Audentes Therapeutics, Inc
BOLD
$10.9M 0.4%
275,000
CELG
75
DELISTED
Celgene Corp
CELG
$10.7M 0.39%
120,000
-241,000
-67% -$21.3M

Similar funds

Eventide Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Eventide Asset Management held 156 positions worth $2.72B, up 13% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $128M of net new capital in Q3 2018, opening 12 new positions and adding to 32 existing holdings. Its largest new stake was SendGrid, Inc.: 1,968,653 shares worth $72.4M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $42M trimmed.

  • Eventide Asset Management's largest Q3 2018 buy was SendGrid, Inc.: 1,968,653 shares worth $72.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q3 2018, an estimated $35.9M increase.
  • Eventide Asset Management's biggest Q3 2018 reduction was AbbVie, cutting an estimated $42M.
  • Eventide Asset Management fully exited Integrated Device Technology I in Q3 2018, selling an estimated $26.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $2.72B portfolio in Q3 2018.
  • Eventide Asset Management opened 12 new positions and closed 11 in Q3 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.72B.

Based on Eventide Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.